Follow Sector Rotation This Week in Midst of War with Iran…Update-3…Energy
What is your portfolio allocation by sector?
Large Cap Biopharmaceuticals: Still a Core Position for Your Portfolio…Update-2
Update-2 3/6/26... After the close learned that UBS upgraded biopharma stocks. Will review the sector over the weekend. XBI turned green and flat not down at the close. The IBB found buyers at $167. XNCR was up 1.35 at $11. Update-1 3/5/26 8:45A...Biotech stocks weak Royalty issues with XENCOR!...
Late February Doldrums: A Week for Trading SMID Caps and Rebalancing…Update-3…sector watch biotech!
Update 3/1/26: Get ready to rebalance your portfolio with War in Iran. Precious metals, energy, materials and Aerospace/ Defense stocks can be an initial focus. Check futures at 6P PST Sunday evening. Update-2 2/24/26,,,Fears of AI disruption continues to dominate technology shares as traders...
Wild Week of Rotation: Sector Performance 2026…Update-3… 2/12/26…the AI effect!
Update-3 2/15/26...More rotation ahead or waiting for Trump " State of the Nation?". Biotech stocks peaked on1/22 with the XBI at the $131 handle and now at $122.86. Here are current sector trends YTD: Leaders: Energy Materials Consumer Staples; Laggards: Financials, Information technology,...
Large Cap Biopharmaceuticals: A Core Position for a Healthcare Portfolio…Update-5…hot stock EVMN
Update-5 2/10...Evommune (EVMN) up over 70% to the $29 level on Ph.2 a proof of concept trial for moderate to severe atopic dermatitis. The Company completed an IPO at $16/sh in NOV. '25 for proceeds of $172M. REGN was down on the announcement but presented 36 abstracts at the AAAI Allergy...